PFE
Pfizer Inc
28.20$
+0.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.6% | 36.0% | 7.3% | -13.4% | 37.9% | 37.8% | 17.0% | -4.0% | 27.6% | 30.5% | 18.1% | 5.6% | 21.0% | |
| 11.6% | 11.5% | 11.7% | 13.0% | 9.9% | 10.1% | 11.8% | 11.1% | 10.0% | 9.6% | 11.2% | 10.8% | 10.3% | |
| 1.1% | 0.8% | 1.5% | 1.6% | 1.5% | 1.0% | 1.2% | 1.4% | 1.2% | 1.3% | 1.9% | 1.7% | 1.5% | |
| -8.9% | 58.0% | -22.4% | -26.6% | 5.0% | 16.5% | -14.0% | 13.1% | -0.2% | 9.1% | -12.0% | -12.1% | -3.1% | |
| 6.0% | 7.2% | 4.7% | 4.8% | 3.7% | 5.2% | 4.1% | 4.2% | 3.6% | 4.8% | 3.0% | 3.5% | 3.8% | |
| 6.6% | -75.5% | 11.6% | 34.6% | -11.6% | -9.1% | 23.9% | 27.0% | -14.6% | -35.0% | 5.4% | 14.0% | -8.9% | |
| 17.2% | 15.9% | 15.9% | 17.9% | 13.4% | 13.4% | 17.8% | 16.7% | 14.7% | 13.9% | 16.9% | 16.3% | 15.4% | |
| 0.0% | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | -12.7% | -15.3% | -17.7% | -5.0% | 0.0% | 17.6% | -0.9% | -7.9% | 2.8% | |
| -28.0% | 37.4% | -33.1% | -18.5% | -26.2% | -28.8% | -38.1% | -21.8% | -14.9% | 3.4% | -19.8% | -24.4% | -13.2% | |
| 4.0% | -2.0% | -14.4% | 2.6% | 0.2% | -0.3% | 2.7% | 1.5% | -1.8% | -1.1% | 3.9% | -4.8% | -1.0% | |
| 19.6% | 28.8% | 2.6% | -18.2% | 34.3% | 32.7% | 12.9% | -8.2% | 24.0% | 25.7% | 15.1% | 2.0% | 17.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.